On July 17, 2025, Connect Biopharma Holdings Ltd announced that it regained compliance with Nasdaq's minimum bid price requirement, having maintained a share price above $1.00 for 10 consecutive days, resolving a previous non-compliance issue that started on March 24, 2025.